Based on the role of BCL11B in biology, it is reasonable to hypothesize that BCL11B is involved in the clinical course of HCC as it is treated with various DNA‐damaging chemotherapy and radiotherapy agents. This evidence concerns the gene BCL11B and hepatocellular carcinoma.